StockData
vTv Therapeutics Inc. logo

vTv Therapeutics Inc. (VTVT) stock

VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3062% below fair value
$16.23−1.06 (-6.13%)

Close on Nov 18, 2026Market cap $64.17MP/E –Yield –

vTv Therapeutics cash

Cash and short-term investments held at the end of each period.

vTv Therapeutics's cash was $86.64M at Jun 30, 2026. For fiscal 2025 it was $88.93M, up 142.0% from the year before. Over ten years it grew 0.1% a year on average. The highest annual figure on record is $88.93M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$88.93M+142.0%
FY2024Dec 31, 2024$36.75M+289.0%
FY2023Dec 31, 2023$9.45M-22.1%
FY2022Dec 31, 2022$12.13M-9.6%
FY2021Dec 31, 2021$13.42M+133.4%
FY2020Dec 31, 2020$5.75M+34.4%
FY2019Dec 31, 2019$4.28M+2.2%
FY2018Dec 31, 2018$4.18M-71.0%
FY2017Dec 31, 2017$14.42M-72.0%
FY2016Dec 31, 2016$51.51M-41.5%
FY2015Dec 31, 2015$88.00M+6258.6%
FY2014Dec 31, 2014$1.38M+27.1%
FY2013Dec 31, 2013$1.09M-48.7%
FY2012Dec 31, 2012$2.12M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$86.64M+234.2%
Q1 FY2026Mar 31, 2026$98.09M+215.8%
Q4 FY2025Dec 31, 2025$88.93M+142.0%
Q3 FY2025Sep 30, 2025$98.50M+137.0%
Q2 FY2025Jun 30, 2025$25.92M-43.1%
Q1 FY2025Mar 31, 2025$31.06M-40.6%
Q4 FY2024Dec 31, 2024$36.75M+289.0%
Q3 FY2024Sep 30, 2024$41.57M+404.6%
Q2 FY2024Jun 30, 2024$45.53M+261.3%
Q1 FY2024Mar 31, 2024$52.26M+178.5%
Q4 FY2023Dec 31, 2023$9.45M-22.1%
Q3 FY2023Sep 30, 2023$8.24M-46.3%
Q2 FY2023Jun 30, 2023$12.60M-29.5%
Q1 FY2023Mar 31, 2023$18.77M+54.6%
Q4 FY2022Dec 31, 2022$12.13M-9.6%
Q3 FY2022Sep 30, 2022$15.34M-21.6%
Q2 FY2022Jun 30, 2022$17.86M+64.9%
Q1 FY2022Mar 31, 2022$12.14M+43.7%
Q4 FY2021Dec 31, 2021$13.42M+133.4%
Q3 FY2021Sep 30, 2021$19.57M+970.9%
Q2 FY2021Jun 30, 2021$10.84M+69.5%
Q1 FY2021Mar 31, 2021$8.45M+190.7%
Q4 FY2020Dec 31, 2020$5.75M+34.4%
Q3 FY2020Sep 30, 2020$1.83M-63.0%
Q2 FY2020Jun 30, 2020$6.39M+61.3%
Q1 FY2020Mar 31, 2020$2.91M-61.0%
Q4 FY2019Dec 31, 2019$4.28M+2.2%
Q3 FY2019Sep 30, 2019$4.94M-21.2%
Q2 FY2019Jun 30, 2019$3.96M+8.2%
Q1 FY2019Mar 31, 2019$7.46M-17.4%
Q4 FY2018Dec 31, 2018$4.18M-71.0%
Q3 FY2018Sep 30, 2018$6.27M-69.8%
Q2 FY2018Jun 30, 2018$3.66M-88.7%
Q1 FY2018Mar 31, 2018$9.04M-80.0%
Q4 FY2017Dec 31, 2017$14.42M-72.0%
Q3 FY2017Sep 30, 2017$20.77M-59.3%
Q2 FY2017Jun 30, 2017$32.51M–
Q1 FY2017Mar 31, 2017$45.15M–
Q4 FY2016Dec 31, 2016$51.51M–
Q3 FY2016Sep 30, 2016$51.06M–

More vTv Therapeutics figures

See a number that looks wrong?